eCite Digital Repository
Analysis of the epigenome in multiplex pre-eclampsia families identifies SORD, DGKI, and ICA1 as novel candidate risk genes
Citation
Ariff, A and Melton, PE and Brennecke, SP and Moses, EK, Analysis of the epigenome in multiplex pre-eclampsia families identifies SORD, DGKI, and ICA1 as novel candidate risk genes, Frontiers in Genetics, 10 pp. 1-11. ISSN 1664-8021 (2019) [Refereed Article]
![]() | PDF 4Mb |
Copyright Statement
Copyright 2019 Ariff, Melton, Brennecke and Moses. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)
DOI: doi:10.3389/fgene.2019.00227
Abstract
Pre-eclampsia is a serious heritable disorder that affects 5-8% of pregnancies worldwide. While classical genetic studies have identified several susceptibility genes they do not fully explain the heritability of pre-eclampsia. An additional contribution to risk can be quantified by examining the epigenome, in particular the methylome, which is a representation of interactions between environmental and genetic influences on the phenotype. Current array-based epigenetic studies only examine 2-5% of the methylome. Here, we used whole-genome bisulfite sequencing (WGBS) to determine the entire methylome of 13 individuals from two multiplex pre-eclampsia families, comprising one woman with eclampsia, six women with pre-eclampsia, four women with uncomplicated normotensive pregnancies and two male relatives. The analysis of WGBS profiles using two bioinformatics platforms, BSmooth and Bismark, revealed 18,909 differentially methylated CpGs and 4157 differentially methylated regions (DMRs) concordant in females. The methylation patterns support the involvement of previously reported candidate genes, including COL4A1, SLC2A4, PER3, FLT1, GPI, LCT, DDAH1, TGFB3, DLX5, and LRP1B. Statistical analysis of DMRs revealed three novel genes significantly correlated with pre-eclampsia: sorbitol dehydrogenase (SORD, p = 9.98 × 10-6), diacylglycerol kinase iota (DGKI, p = 2.52 × 10-5), and islet cell autoantigen 1 (ICA1, 7.54 × 10-3), demonstrating the potential of WGBS in families for elucidating the role of epigenome in pre-eclampsia and other complex diseases.
Item Details
Item Type: | Refereed Article |
---|---|
Keywords: | DGK, DNA methylation (CpG), ICA, SORD, differentially methylated region (DMR), epigenetics, pre-eclampsia, whole-genome bisulfite sequencing (WGBS) |
Research Division: | Biological Sciences |
Research Group: | Genetics |
Research Field: | Epigenetics (incl. genome methylation and epigenomics) |
Objective Division: | Health |
Objective Group: | Clinical health |
Objective Field: | Clinical health not elsewhere classified |
UTAS Author: | Melton, PE (Dr Phillip Melton) |
UTAS Author: | Moses, EK (Professor Eric Moses) |
ID Code: | 141385 |
Year Published: | 2019 |
Web of Science® Times Cited: | 5 |
Deposited By: | Menzies Institute for Medical Research |
Deposited On: | 2020-10-16 |
Last Modified: | 2021-10-07 |
Downloads: | 8 View Download Statistics |
Repository Staff Only: item control page